RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHUMBLINE ADVISERS | 257,975 | $1,927,073 | 0.00% |
| Skandinaviska Enskilda Banken AB (publ) | 47,800 | $358 | 0.00% |
| STATE STREET CORP | 5,697,932 | $42,563,552 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,000,777 | $7,475,804 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 784,788 | $5,862,216 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 2,809,143 | $20,984,305 | 0.00% |
| O'Dell Group, LLC | 1,175 | $8,778 | 0.00% |
| VANGUARD GROUP INC | 11,259,832 | $84,110,946 | 0.00% |
| Arizona State Retirement System | 36,068 | $269,428 | 0.00% |
| ALLIANCEBERNSTEIN L.P. | 308,662 | $2,305,705 | 0.00% |
| Swiss National Bank | 279,500 | $2,087,865 | 0.00% |
| Russell Investments Group, Ltd. | 75,301 | $562,497 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 81,176 | $605,399 | 0.00% |
| Bank of New York Mellon Corp | 596,693 | $4,457,296 | 0.00% |
| Handelsbanken Fonder AB | 22,400 | $167 | 0.00% |
| CITIGROUP INC | 177,338 | $1,324,715 | 0.00% |
| Citadel Advisors | 737,758 | $5,511,052 | 0.00% |
| GUGGENHEIM CAPITAL LLC | 16,812 | $125,585 | 0.00% |
| GOLDMAN SACHS GROUP INC | 577,445 | $4,313,515 | 0.00% |
| SIGNATUREFD, LLC | 4,342 | $32,435 | 0.00% |
External links
This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q2 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.